(19)
(11)
EP 1 626 986 A2
(12)
(88)
Date of publication A3:
20.01.2005
(43)
Date of publication:
22.02.2006
Bulletin 2006/08
(21)
Application number:
04732961.0
(22)
Date of filing:
14.05.2004
(51)
International Patent Classification (IPC):
C07K
14/47
(1995.01)
G01N
33/53
(1985.01)
C07K
16/18
(1995.01)
G01N
33/50
(1980.01)
(86)
International application number:
PCT/EP2004/005195
(87)
International publication number:
WO 2004/101615
(
25.11.2004
Gazette 2004/48)
(84)
Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
(30)
Priority:
16.05.2003
US 471061 P
(71)
Applicants:
Genova Ltd.
Hamilton HM12 (BM)
Novartis Pharma GmbH
1230 Wien (AT)
AT
(72)
Inventors:
BOUGUELERET, Lydie
1217 Meyrin (CH)
MAHE, Eve
1217 Meyrin (CH)
(74)
Representative:
Leon, Susanna Iris et al
Novartis AG Corporate Intellectual Property P.O. Box
4002 Basel
4002 Basel (CH)
(54)
SECRETED POLYPEPTIDE SPECIES ASSOCIATED WITH CARDIOVASCULAR DISORDERS